Presentations Medicenna Therapeutics Corp. - Corporate Presentation Q4 November 2020 Upcoming Events December 11, 2020 at 11:00 AM EST Medicenna KOL Call on MDNA55 for the Treatment of Recurrent Glioblastoma Multiforme Go to Past Events October 29, 2020 from 11:00 AM to 12:30 PM EDT Virtual TSX Life Sciences Investor Day Go to October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to October 1, 2020 at 12:30 PM EDT Virtual Gravitas Healthcare Investor Day Go to September 30, 2020 at 10:00 AM EDT Medicenna Annual and Special Meeting Go to September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Next page next › Last page last »
December 11, 2020 at 11:00 AM EST Medicenna KOL Call on MDNA55 for the Treatment of Recurrent Glioblastoma Multiforme Go to
October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to
October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to
September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to
